ONC201

ONC201 is an experimental drug developed to treat certain cancers, such as glioblastoma and some forms of lymphoma. It works by targeting specific pathways inside cancer cells, prompting them to self-destruct and reducing tumor growth. Unlike traditional chemotherapy, ONC201 activates the body’s own mechanisms to fight cancer more selectively. Researchers are studying its effectiveness and safety in clinical trials, aiming to provide a novel option for patients with limited treatment choices. While promising, it is still in the development phase and not yet widely available outside research settings.